Medimaps Group

Medimaps Group is a leading global medical software analytics company founded by a group of clinical practitioners and researchers, based in Switzerland with offices in the US and in France. It specialises in the engineering, research, development, and commercialisation of medical software applications based on patented multi-purpose technologies.

Its flagship product, the TBS iNsight™ (Osteo) software application has been used for years in clinical practice to better predict fracture risk in the field of osteoporosis. It has become the gold standard for bone structure assessment in routine clinical practice.

This core technology has been further developed and new medical applications have been created in the dental and orthopaedics fields. Medimaps is also exploring applications in veterinary medicine and oncology.

Used in the field of osteoporosis, TBS iNsight™ (Osteo) is an advanced imaging software application for bone densitometers (DXA). It provides doctors with a simple solution to better predict a patient’s risk for bone fracture; to fine-tune therapy decision; and to improve patient management.

TBS iNsight™ is a Medical Device that is CE 2797 marked & has been cleared to be sold in the US.

Our team of experts provides better medical outcomes by giving doctors innovative digital health solutions to identify patients at clinical risk, fine-tune therapy decisions and improve disease management.